miLens

The New Frontier in Ophthalmic Care

Clinical-stage ophthalmic technology company developing breakthrough continuous IOP monitoring. FDA pivotal trials underway for electronics-free contact lens solution.

Preview

Total Patients

247

Across all practices

Active Sessions

18

IOP monitoring

Recent Patients

NameDOBStatus
Sarah Johnson
ID: 12345
1985-03-15
Active
Michael Chen
ID: 12346
1978-11-22
Monitoring
Emily Rodriguez
ID: 12347
1992-07-08
Active

IOP Session

Active
Session ID: ABC1234
Started: Today, 8:00 AM
Next measurement in 45 min
Measurements
12/24
Completion
50%

Transforming Anterior Segment Disease Management

Smartlens is redefining anterior segment disease management through breakthrough technologies that address critical unmet needs. We're enabling a paradigm shift from episodic office visits to continuous, data-driven treatment across multiple conditions. By combining novel microfluidic technology with AI-enhanced diagnostics, we enable precise, real-time tracking and personalized care management for glaucoma and beyond.

Glaucoma in Numbers

The global burden of glaucoma and the urgent need for better monitoring

~80M
People with glaucoma worldwide (est. 186M by 2060)
~50%
Undiagnosed glaucoma cases in the US
$11.3M
Raised in verified funding from leading investors
Feb 2026
Expected completion of FDA pivotal trial

Technology Portfolio

Redefining care for anterior segment diseases through breakthrough monitoring, diagnostics, and treatment technologies

miLens™

In U.S. Pivotal Trials

The world's smallest wearable microfluidic device for remote IOP monitoring. Non-invasive, electronics-free contact lens design works seamlessly with our AI-powered smartphone imaging system. Currently enrolling ~125 subjects in FDA pivotal trial (NCT06689696).

24-Hour MonitoringUltra-Sensitive TechnologyPatent Protected

Slit IQ™

In Development

AI-powered remote examination platform in development for comprehensive anterior segment exams with clinical-grade standardization. Designed to expand specialist access and reduce unnecessary in-person visits through telemedicine.

Telemedicine EnabledAI-EnhancedClinical-Grade

THERx IQ™

Early Development

Novel wearable device addressing poor medication adherence through automated micro-dose delivery. Programmable platform optimizes treatment timing based on actual diurnal IOP patterns, enhancing therapeutic efficacy while minimizing side effects.

Automated DosingProgrammableMicro-Dosing

miLens IQ+™

AI/ML Platform

AI/ML-powered platform unlocking insights from first-of-its-kind diurnal IOP monitoring and comprehensive imaging data. Provides real-time risk stratification and predictive capabilities for early intervention before significant disease progression.

Predictive AnalyticsRisk StratificationData Integration

Complete Practice Management

Everything you need to manage your ophthalmology practice and monitor patient IOP data

Real-Time Data Access

Access patient IOP data in real-time through our cloud platform. Monitor trends, view historical data, and generate comprehensive reports for better clinical decision-making.

Multi-Practice Management

Manage multiple clinic locations from a single dashboard. Role-based access control ensures HIPAA-compliant data handling across your organization.

Secure & Compliant

Enterprise-grade security with full audit trails. Built for HIPAA compliance with encrypted data storage and transmission to protect patient privacy.

Ready to Transform Your Practice?

Join healthcare providers who are revolutionizing glaucoma care with continuous IOP monitoring.

Smart Lens
© 2015 - 2026 Smartlens, Inc. All rights reserved.